Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer

Clinical Editorial

British Journal of Cancer, Published online: 10 April 2026; doi:10.1038/s41416-026-03432-y Genome-wide methylome profiling of cell-free DNA enables prognostication of patients with castration-resistant prostate cancer

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Statistical Analysis Plan for the SImPLE Trial: Effects of Illustrations and Plain Language on Con

Oncology • 27 Jul 2026

Cancer epidemiology in Khyber Pakhtunkhwa, Pakistan (2020–2023): incidence counts and ASIRs

Oncology • 22 Jul 2026

Quantitative collagen and ECM features predict prostate cancer recurrence after radiotherapy

Oncology • 17 Jul 2026

ClinicalTrialsRelated by Conditionprostate cancer

Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy

Oncology • 08 Apr 2026

ClinicalTrialsRelated by Conditionprostate cancer

A Phase Ib/II Open-Label Study Of AMO959 With 177Lu-PSMA-617 In Combination With An ARPI In PSMA

Oncology • 01 Apr 2026

Prostate MRI Beyond Diagnosis

Oncology • 02 Apr 2026